Reuben Shaw, PhD, is the director of the National Cancer Institute–Designated Cancer Center and the William R. Brody Chair at the Salk Institute in La Jolla, California.
He is also currently an adjunct professor in molecular biology at UC San Diego.
His experience includes 25 years of research on tumor suppressor and oncogene signaling pathways, cell growth, and metabolic control, including several research discoveries that he and his lab have continued to pursue from basic biochemistry and cell biology all the way through to preclinical trials. Research in the Shaw lab at the Salk Institute centers on decoding metabolic pathways that are deranged in different genetic subsets of cancer. In particular, the Shaw lab has focused on how various kinases sense changes in cellular energy and coordinate that with mitochondrial function and turnover.